News and Events - Affimed

News

All categories

Earnings

Press Release

All years

2023

2022

2021

2020

2019

2018

2017

2016

2015

2014

Affimed To Provide a Clinical Update on AFM24 Monotherapy Dose-escalation at European Society for Medical Oncology (ESMO) Congress 2022

September 5, 2022

Affimed to Present at Upcoming Investor Conferences

September 1, 2022

Affimed Reports Second Quarter 2022 Financial Results and Highlights Recent Operational Progress

August 11, 2022

Affimed to Report Second Quarter 2022 Financial Results & Corporate Update on August 11, 2022

August 4, 2022

Affimed Establishes Scientific Advisory Board

June 30, 2022

Affimed Presents Preclinical Data of Novel Innate Cell Engager AFM28 at the Annual Meeting of the European Hematology Association (EHA)

June 10, 2022

Affimed Reports First Quarter 2022 Financial Results and Highlights Recent Operational Progress

June 1, 2022

Affimed Highlights Trial Designs of Three AFM24 Ongoing Clinical Studies at the Annual Meeting of the American Society of Clinical Oncology (ASCO)

May 26, 2022

Affimed to Present at the 2022 Jefferies Healthcare Conference

May 26, 2022

Affimed Announces Annual General Meeting of Shareholders

May 24, 2022

Events

All

Scientific

Investors

26Sep

NK2023

September 26 - 29, 2023 (Oslo, Norway)

Webcasts More events